» Articles » PMID: 21683299

Measurement of Reticulocyte and Red Blood Cell Indices in the Evaluation of Anemia in Inflammatory Bowel Disease

Overview
Date 2011 Jun 21
PMID 21683299
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The commonest types of anemia in inflammatory bowel disease (IBD) are iron deficiency (IDA) and anemia of chronic disease. The differentiation between these two conditions is important for the management of the patient. The aim of this study was to investigate the usefulness of reticulocyte and red blood cell indices in the evaluation of anemia in IBD.

Methods: One hundred IBD patients [49 ulcerative colitis (UC), 51 Crohn's disease (CD)] and 102 healthy controls were enrolled. Measurement of reticulocyte and red blood cell indices was performed using the Coulter LH780 Hematology Analyzer (Beckman Coulter). Additionally, serum levels of ferritin, transferrin saturation (Tsat) and soluble transferrin receptor (sTfR) were analyzed in all patients and controls.

Results: The prevalence of anemia was 41.2% for UC and 42.9% for CD, whereas 30 IBD patients (30%) had IDA. Red cell Distribution Width (RDW), Red blood cell Size Factor (RSF), and Reticulocyte Distribution Width-Coefficient of Variation (RDWR-CV) were found significantly correlated with both Tsat and sTfR but not with ferritin levels. Patients with IDA had significantly higher RDW and RDWR-CV and significantly lower RSF levels compared with those without IDA. High values of RDW (sensitivity 93%, specificity 81%) and low values of RSF (sensitivity 83%, specificity 82%) were the best markers for the diagnosis of IDA. Both RDWR-CV and RDWR-SD were significantly correlated with disease activity and CRP levels.

Conclusion: RDW, RSF and RDWR, could be useful markers for the evaluation of anemia and disease activity in IBD.

Citing Articles

Evaluation of CSF 8-iso-prostaglandin F2α and erythrocyte anisocytosis as prognostic biomarkers for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Wisniewski K, Zaczkowski K, Szmyd B, Popeda M, Bienkowski M, Posmyk B Sci Rep. 2024; 14(1):11302.

PMID: 38760404 PMC: 11101481. DOI: 10.1038/s41598-024-61956-w.


Red Blood Cell Distribution Width: A Potential Inexpensive Marker for Disease Activity in Patients with Rheumatic Diseases; Scoping Review.

Alghamdi M Open Access Rheumatol. 2023; 15:173-180.

PMID: 37719317 PMC: 10505028. DOI: 10.2147/OARRR.S424168.


Prevalence and Risk Factors of Anemia in Inflammatory Bowel Diseases: A Case-Control Study.

Aslam T, Mehmood A Cureus. 2023; 15(7):e41990.

PMID: 37593267 PMC: 10427948. DOI: 10.7759/cureus.41990.


Iron Therapy in Inflammatory Bowel Disease.

Kumar A, Brookes M Nutrients. 2020; 12(11).

PMID: 33198376 PMC: 7697745. DOI: 10.3390/nu12113478.


Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review.

Katsaros M, Paschos P, Giouleme O Ann Gastroenterol. 2020; 33(4):348-354.

PMID: 32624654 PMC: 7315702. DOI: 10.20524/aog.2020.0486.